NYSE Composite ended the session with Novartis rising 2.52% to $93.50 on Tuesday while nYSE Composite fell 0.1% to $14,390.70.
Novartis today’s close was $93.50, 6.78% under its 52-week high of $99.84.
Novartis’s sales growth is 3.9% for the current quarter and 6.3% for the next. The company’s growth estimates for the present quarter and the next is 2.3% and 1.3%, respectively.
Year-on-year quarterly revenue growth grew by 0.4%, now sitting on 49.58B for the twelve trailing months.
Novartis’s last day, last week, and last month’s average volatility was 2.99%, 0.06%, and 0.11%, respectively.
Novartis’s last day, last week, and last month’s high and low average amplitude percentage was 1.31%, 0.93%, and 1.07%, respectively.
Novartis’s Stock Yearly Top and Bottom Value
Novartis’s stock is valued at $93.50 at 16:23 EST, under its 52-week high of $99.84 and way above its 52-week low of $69.18.
Novartis’s Moving Average
Novartis’s worth is above its 50-day moving average of $89.02 and higher than its 200-day moving average of $86.97.